{"doi":"10.1128/cmr.00162-20","title":"Remdesivir against COVID-19 and Other Viral Diseases","abstract":"<jats:p>Patients and physicians worldwide are facing tremendous health care hazards that are caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) pandemic. Remdesivir (GS-5734) is the first approved treatment for severe coronavirus disease 2019 (COVID-19). It is a novel nucleoside analog with a broad antiviral activity spectrum among RNA viruses, including ebolavirus (EBOV) and the respiratory pathogens Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV, and SARS-CoV-2.</jats:p>","journal":"Clinical Microbiology Reviews","year":2020,"id":618148,"datarank":0.855066536008603,"base_score":5.700443573390686,"endowment":5.700443573390686,"self_citation_contribution":0.855066536008603,"citation_network_contribution":0.0,"self_endowment_contribution":0.855066536008603,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":298,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1072045,"name":"Isabelle Suárez","orcid":"0000-0002-9863-9675","position":1,"is_corresponding":false},{"id":1594472,"name":"Vanessa Priesner","orcid":null,"position":2,"is_corresponding":false},{"id":103447,"name":"Gerd Fätkenheuer","orcid":"0000-0002-5054-1871","position":3,"is_corresponding":false},{"id":28450,"name":"Jan Rybniker","orcid":"0000-0001-8351-2690","position":4,"is_corresponding":false},{"id":1239703,"name":"Jakob J Malin","orcid":"0000-0002-2989-0436","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Remdesivir against COVID-19 and Other Viral Diseases","abstract":"<jats:p>Patients and physicians worldwide are facing tremendous health care hazards that are caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) pandemic. Remdesivir (GS-5734) is the first approved treatment for severe coronavirus disease 2019 (COVID-19). It is a novel nucleoside analog with a broad antiviral activity spectrum among RNA viruses, including ebolavirus (EBOV) and the respiratory pathogens Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV, and SARS-CoV-2.</jats:p>","is_dataset_classified":null,"base_score":5.700443573390686,"endowment":5.700443573390686,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"33055231","pmcid":"PMC7566896","openalex_id":"https://openalex.org/W3093244828","authors":[],"funders":[],"total_grants":0,"fwci":5.2227,"citation_percentile":0.96919577,"influential_citations":0,"citation_trend":[{"year":2020,"count":4},{"year":2021,"count":79},{"year":2022,"count":87},{"year":2023,"count":46},{"year":2024,"count":44},{"year":2025,"count":30},{"year":2026,"count":8}],"oa_status":"green","license":"https://journals.asm.org/non-commercial-tdm-license","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7566896","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7566896","host_type":"repository"},{"url":"https://journals.asm.org/doi/pdf/10.1128/CMR.00162-20","host_type":"publisher"},{"url":"https://doi.org/10.1128/cmr.00162-20","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/33055231","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC7566896","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC7566896?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["COVID-19 Clinical Research Studies","SARS-CoV-2 and COVID-19 Research","COVID-19 Impact on Reproduction","Adenosine Monophosphate","Alanine","Antiviral Agents","Betacoronavirus","COVID-19","Clinical Trials as Topic","Compassionate Use Trials","Coronavirus Infections","Drug Administration Schedule","Ebolavirus","Hemorrhagic Fever, Ebola","Humans","Middle East Respiratory Syndrome Coronavirus","Pandemics","Patient Safety","Pneumonia, Viral","Severe acute respiratory syndrome-related coronavirus","SARS-CoV-2","Severe Acute Respiratory Syndrome","Survival Analysis","Treatment Outcome"],"mesh_terms":["Betacoronavirus","COVID-19","SARS-CoV-2","Adenosine Monophosphate","Alanine","Antiviral Agents","Clinical Trials as Topic","Drug Administration Schedule","Humans","Pneumonia, Viral","Survival Analysis","Treatment Outcome","Coronavirus Infections","Hemorrhagic Fever, Ebola","Ebolavirus","Severe Acute Respiratory Syndrome","Severe acute respiratory syndrome-related coronavirus","Compassionate Use Trials","Pandemics","Patient Safety","Middle East Respiratory Syndrome Coronavirus"],"keywords":["Coronavirus disease 2019 (COVID-19)","2019-20 coronavirus outbreak","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Virology","Betacoronavirus","Coronavirus Infections","Medicine","Outbreak","Internal medicine","Infectious disease (medical specialty)","Disease","Antiviral","SARS-Cov","Coronavirus","Ebolavirus","Mers-cov","Remdesivir","Covid-19","Sars-cov-2"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T03:36:10.564735Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}